

Stagwell vs FIGS
Stagwell runs a challenger network of digital-first marketing and communications agencies competing against holdco giants, while FIGS sells premium scrubs and medical apparel directly to healthcare professionals online. Stagwell vs FIGS pairs two growth-oriented businesses built around modern brand-building and digital distribution, each fighting to prove its model scales profitably. Readers see how agency economics compare to direct-to-consumer apparel margins and which story has more durable earnings momentum.
Stagwell runs a challenger network of digital-first marketing and communications agencies competing against holdco giants, while FIGS sells premium scrubs and medical apparel directly to healthcare pr...
Investment Analysis

Stagwell
STGW
Pros
- Stagwell demonstrated strong revenue growth in Q3 2025, with total net revenue up 4% year-over-year and digital transformation revenue increasing 12%.
- The company maintains solid profitability, achieving a 19% adjusted EBITDA margin and projecting adjusted EBITDA between $410 million and $460 million for 2025.
- Stagwell's strategic partnership with Palantir boosts its AI capabilities, enhancing competitive positioning in digital marketing and data-driven services.
Considerations
- Despite recent growth, Stagwell's valuation is high with a P/E ratio exceeding 500, indicating richly priced stock relative to current earnings.
- The stock has experienced significant price volatility in the past year, trading between $4.03 and $8.18, which may reflect market uncertainty.
- Stagwell's advocacy business is cyclical and currently in a pullback phase, which could pressure revenue growth in some segments.

FIGS
FIGS
Pros
- FIGS is a specialised healthcare apparel company with a growing customer base driven by strong brand recognition within medical professionals.
- The company has demonstrated robust top-line growth supported by direct-to-consumer e-commerce and expanding wholesale channels.
- FIGS benefits from increasing demand for premium, functional medical apparel that commands higher margins and loyalty.
Considerations
- FIGS operates in a competitive retail market with risks from macroeconomic headwinds that may impact discretionary spending on apparel.
- Profitability remains challenged due to investments in growth, marketing, and inventory expansion that pressure margins.
- The company faces supply chain risks and potential disruptions that could affect inventory levels and delivery timelines.
Buy STGW or FIGS in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


